Percutaneous coronary intervention

Percutaneous Coronary Intervention

The global percutaneous aortic valve implantation market is predicted to see striking growth by 2031, due to the rising cases of cardiovascular diseases. This growth is expected to have a significant impact on the healthcare industry, particularly in the field of percutaneous coronary intervention.

What is Percutaneous Coronary Intervention?

Percutaneous coronary intervention, also known as coronary angioplasty, is a non-surgical procedure used to treat narrowed or blocked coronary arteries. During the procedure, a thin, flexible tube called a catheter is inserted into a blood vessel in the arm or groin and threaded to the blocked artery. A small balloon at the tip of the catheter is then inflated to widen the artery and improve blood flow to the heart.

Benefits of Percutaneous Coronary Intervention

Percutaneous coronary intervention is a minimally invasive procedure that can help relieve symptoms of coronary artery disease, such as chest pain and shortness of breath. It can also reduce the risk of heart attack and other complications associated with blocked arteries. With the growing prevalence of cardiovascular diseases worldwide, percutaneous coronary intervention is becoming an increasingly important treatment option for patients in need of coronary artery revascularization.